Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

NCT01024231

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • Medstar Georgetown-Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Memorial Sloan Kettering Nassau New York, United States
  • Hillman Cancer Research Pavilion Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer

NCT02718066

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations
  • [Site 02] Mayo Clinic Arizona Phoenix, Arizona, United States
  • [Site 11] University of California, San Diego Medical Center La Jolla, California, United States
  • [Site 01] Hematology - Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • [Site 09] H. Lee Moffitt Cancer Center and Research Institute, Inc. Tampa, Florida, United States
View Trial Details

Related conditions